Brief: Beam Therapeutics Announces FDA Lifting Clinical Hold On IND Application For Beam-201

Beam Therapeutics

02/12/2022 11:36

Dec 2 (Reuters) - Beam Therapeutics Inc  BEAM.O :
    * BEAM THERAPEUTICS ANNOUNCES FDA HAS LIFTED THE CLINICAL
HOLD ON
THE INVESTIGATIONAL NEW DRUG APPLICATION FOR BEAM-201
    * BEAM THERAPEUTICS INC - LOOK FORWARD TO PROVIDING UPDATES
ON
NEXT STEPS FOR PROGRAM IN 2023
    * BEAM THERAPEUTICS INC - FDA HAS LIFTED CLINICAL HOLD AND
CLEARED
INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR BEAM-201

Source text for Eikon:  ID:nGNX6mBwnW 
Further company coverage:  BEAM.O 
 ((Reuters.Briefs@thomsonreuters.com;))